94517 ⎘
Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems; Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2; Oxygen atoms with an aryl radical attached in position 4
PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF
#2TETRAHYDROQUINAZOLINE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS
#3DIHYDROQUINAZOLINONES AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD
#4Saturated-ring-fused dihydropyrimidinone or dihydrotriazinone compounds and pharmaceutical use thereof
#5STK19 inhibitors for treatment of cancer
#6SATURATED-RING-FUSED DIHYDROPYRIMIDINONE OR DIHYDROTRIAZINONE COMPOUNDS AND PHARMACEUTICAL USE THEREOF
#7Compounds having fluorene structures
#8Inhibitors of paxillin function and related compositions and methods
#9COMPOUNDS FOR USE IN SCREENING METHODS FOR SPINAL MUSCULAR ATROPHY
#10Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
#11Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
#12Screening methods for spinal muscular atrophy
#13Substituted isoquinolinones and quinazolinones
#14Substituted isoquinolinones and quinazolinones
#15Quinazolinone T-Type Calcium Channel Antagonists
#16P-38 Kinase Inhibitors
#17Quinazolinone T-Type Calcium Channel Antagonists
#18Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives
#19Quinazolinone T-type calcium channel antagonists
#202-quinazolinone compounds and methods of use
#21Benzamide derivatives as p-38 kinase inhibitors
#22Aryl-quinazoline/aryl-2-amino-phenyl methanone derivatives
#23p-38 kinase inhibitors